Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints
1 other identifier
interventional
10
1 country
1
Brief Summary
This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2019
CompletedFirst Submitted
Initial submission to the registry
March 19, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2019
CompletedFebruary 26, 2021
February 1, 2021
7 months
March 19, 2019
February 23, 2021
Conditions
Outcome Measures
Primary Outcomes (8)
hip or knee osteoarthritis
Radiographic imaging. Kellgren \& Lawrence classification and joint space width will be measured
One day
Lower extremity strength
30 seconds sit to stand test, measuring strength in lower extremities
one day
Lower extremity function
Single leg hop tests
one day
Aerob capasity
Stair test, 18 steps up and down three times
one day
measure of health related quality of life with EQ-5D-5L
participants report the extent of problems they have with endpoints 1-5, where 1 is no problems and 5 is not able to in the five dimensions mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The questionnaire also contains a vertical analogue scale with the labelled endpoints 0-100 where 0 is the worst imaginable health state and 100 the best imaginable health state, giving a valuation of the participants own health state that can be used as a quantitative measure of health outcome based on the patients' own judgement
one day
measure of function and pain with Knee Osteoarthritis Outcome Score (KOOS)
The participant answer questions regarding pain, function, stiffness and quality of life regarding knee pain. Endpoints 0 - 4, where 0 indicate no problems and 4 indicate extreme problems
one day
measuring physical activity level with International Physical Activity Questionnaire (IPAQ)
Participants answer the amount of time being in vigorous activity, moderate activity, walking and sitting during the last 7 days. Answers are given in number of days in each of the activity categories, and time in hours and minutes on a regular day the actual week
one day
Active range of motion
Hand held goniometric measurement of active range of motion in hip and knee bilaterally
one day
Study Arms (1)
Evaluating function, Radiographic imaging, Forms
OTHER* Tests for lower extremity function * Evaluating arthritis of hip and knee, leg length discrepancy and axis deviation radiographically * Evaluating quality of life, function and pain by forms
Interventions
Evaluating arthritis in knee and hip bilaterally. Evaluating axis deficiancy and leg length discrepancy.
Test function and physical capasity
Forms for evaluating quality of life, pain, function
Eligibility Criteria
You may qualify if:
- Patients with idiopathic or post traumatic leg length discrepancy who are lengthened with the callutasis method minimum 15 years ago
You may not qualify if:
- Patients that are lenghtened with innate pathology resulting in shortening of the limb, angle deviation and less musculature, for example congenital femoral deficiency or fibula hemimelia.
- Patients with acquired leg length discrepancy who have had infection in knee or hip joint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- Sophies Minde Ortopedicollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0372, Norway
Related Publications (1)
Bjorge PA, Tveter AT, Steen H, Gunderson R, Horn J. Femoral lengthening might impair physical function and lead to structural changes in adjacent joints: 10 patients with 27 to 34 years' follow-up. Acta Orthop. 2021 Jun;92(3):329-334. doi: 10.1080/17453674.2020.1866864. Epub 2021 Jan 7.
PMID: 33410356DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist
Study Record Dates
First Submitted
March 19, 2019
First Posted
May 29, 2019
Study Start
March 6, 2019
Primary Completion
October 11, 2019
Study Completion
October 11, 2019
Last Updated
February 26, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will become avaliable within 6 months of study completion
- Access Criteria
- Shared in an open access publication
IDP that underlie results in a publication